MLPA screening reveals novel subtelomeric rearrangements in holoprosencephaly.
Holoprosencephaly (HPE) is the most common developmental brain anomaly in human, associated with a wide spectrum of presentations. The etiology is heterogeneous, due to environmental and genetic factors. Out of 12 cytogenetic candidate loci previously reported, eight were subtelomeric, including the loci in which two of the four major HPE genes were identified (SHH and TGIF). Recently, we reported that these two genes could be mutated or microdeleted. Therefore, we hypothesized that subtelomeres screening in HPE patients could refine the known subtelomeric candidate loci and identify novel ones. In this study, 181 samples, 72 fetuses and 109 live-born infants, with HPE and a normal karyotype, and 10 patients deleted for SHH or TGIF (3.5 Mb from telomeres) were screened for subtelomeric rearrangements using the multiplex ligation probe-dependent amplification (MLPA) method with two kits. Quantitative PCR was performed when discrepancies were observed between these two kits. We found that known SHH and TGIF microdeletions on 7q and 18p, encompassed their subtelomeric region (3.5 Mb) and were often associated with cryptic gains. Out of the 181 samples, we detected rearrangements in known candidate HPE loci (1q, 20p, and 21q) as well as in other novel subtelomeric locations (1p, 5q, 8p, 17q, 18q, 22q, and Xq) and in the subcentromeric 15q. We also found associations between cryptic subtelomeric gain and loss that may be inherited from a parental balanced translocation, which is helpful for genetic counseling. These findings reinforce the multihit origin for HPE and contribute to the explanation of the wide phenotypic spectrum described in this developmental disorder.
Bendavid
Claude
C
Institut de Génétique et Développement de Rennes, Université de Rennes1, Faculté de Médecine, Rennes, France.
Dubourg
Christèle
C
Pasquier
Laurent
L
Gicquel
Isabelle
I
Le Gallou
Simon
S
Mottier
Stéphanie
S
Durou
Marie-Renée
MR
Henry
Catherine
C
Odent
Sylvie
S
David
Véronique
V
D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D005820:Genetic Testing / Q000379:methods*; D053823:Hedgehog Proteins / Q000235:genetics; D016142:Holoprosencephaly / Q000175:diagnosis / Q000196:embryology / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007231:Infant, Newborn; D012097:Repressor Proteins / Q000235:genetics; D016615:Telomere / Q000235:genetics*
D053823:Hedgehog Proteins; D012097:Repressor Proteins; C509239:SHH protein, human